| Literature DB >> 25779323 |
Sanghyun Cho1, Hyung Sup Lee, Scott Franzblau.
Abstract
Throughput in tuberculosis drug discovery was extremely limited prior to the introduction of microplate-based susceptibility assays. The 96-well Microplate Alamar Blue Assay (MABA) allows for the quantitative determination of drug susceptibility against any strain of replicating Mycobacterium tuberculosis to be completed within a week at minimal cost. The Low-Oxygen Recovery Assay (LORA) uses a recombinant M. tuberculosis expressing luciferase and provides results of drug activity against non-replicating M. tuberculosis surviving under hypoxic conditions. Determining activity against non-replicating M. tuberculosis is an important factor when developing drug candidates against M. tuberculosis. Here we describe a step-by-step procedure for both the MABA and LORA.Entities:
Mesh：
Substances：
Year: 2015 PMID： 25779323 DOI： 10.1007/978-1-4939-2450-9_17
Source DB: PubMed Journal: Methods Mol Biol ISSN： 1064-3745